Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Medartis Holding AG is a Swiss company operating in the medical technology industry, primarily focused on the development, manufacturing, and distribution of orthopedic surgical implants. The company's core products include precision implant systems for surgical fixation of bone fractures and osteotomies, particularly in the areas of the head, hand, wrist, foot, and ankle. Founded in 1997 and headquartered in Basel, Switzerland, Medartis has established a presence in key international markets across Europe, the Americas, and Asia-Pacific. The company's strategic positioning emphasizes innovation in implant technology, aiming for high standards of surgical precision and patient recovery outcomes.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Medartis Holding AGJohnson & Johnson
Last price
CHF 83.25$256.03
Currency
CHF
USD
CHF 1B$617B
68.7229.68
CHF 1.20$8.63
1.170.23
0$5.28
02.09%
Sector
HealthHealth
Employees
1,428138,200
Ticker
Fr. MED$JNJ
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.MED or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.